NCT06982066Recruiting
Improving Communication Between AYA Oncology Patients and Clinicians: A Patient-Centered Intervention
Improving Health-Related Quality of Life Communication Between AYA Oncology Patients and Clinicians: A Patient-Centered Intervention
Source: ClinicalTrials.gov · Last updated 22 Oct 2026
Brief summary (registry, in English)
The overarching goal is to develop and demonstrate proof-of-concept of ReSPECT (Reproductive and Sexual Health Patient Education and Communication Tool), a multi-modal communication intervention to improve adolescent and young adult (AYA)- clinician sexual and reproductive health (SRH) communication in the outpatient oncology clinic setting.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 13 May 2025
- Start date
- 10 Feb 2025
- Primary completion date
- 15 Mar 2029
- Lead sponsor
- Connecticut Children's Medical Center
- Diseases
- Childhood cancers
- NCT number
- NCT06982066
What you commit to
- Study type: Interventional
- Planned participants: 60
- From 10 Feb 2025 to the primary completion date, 15 Mar 2029
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Not currently on cancer-directed therapy.
Other illness
- Insufficient cognitive functioning to complete study measures (as determined by a member of the patient's primary oncology team)
- Pediatric Oncology Clinicians
- 1\. Be a pediatric oncology physician, clinical fellow, or advanced practice provider (including nurse practitioners and physician assistants) that provides clinical care for AYA patients with cancer
Other
- An individual who meets and of the following criteria will be excluded from participation in this study:
- Unable to speak and read English.
Who the study is looking for
- Adolescent and Young Adult Oncology Patients
- In order to be eligible to participate in this study, an individual must meet all of the following criteria:
- Be aged 15-25 years old at time of enrollment.
- Have a cancer diagnosis and currently be on cancer-directed therapy with at least one of the following:
- Chemotherapy: any anticancer drug to treat the cancer diagnosis, including immunotherapy.
- Radiotherapy: any radiotherapy to treat the cancer diagnosis.
- Surgery: any surgery to remove cancer including partial of total resections. Biopsies are not considered surgery.
- Be greater than or equal to 2 months from diagnosis/initiation of therapy, whichever occurred later.
- Be able to speak and read English
- Have permission to participate from a member of the patient's primary oncology team.
- Provision to sign and date the consent/assent form.
- Active study participation of primary oncology clinician
- Patient must have primary oncology care at Connecticut Children's Center for Cancer \& Blood Disorders of Children's Hospital Los Angeles Cancer \& Blood Disease Institute
Age in the registry: 15 years to 25 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Connecticut Children's Medical Center Coordinator of this site? Confirm its status | Hartford | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.